Literature DB >> 24710105

CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation.

Kun Wang1, Bo Long1, Lu-Yu Zhou1, Fang Liu1, Qun-Yong Zhou2, Cui-Yun Liu1, Yuan-Yuan Fan1, Pei-Feng Li1.   

Abstract

Abnormal mitochondrial fission participates in the pathogenesis of many diseases. Long non-coding RNAs (lncRNAs) are emerging as new players in gene regulation, but how lncRNAs operate in the regulation of mitochondrial network is unclear. Here we report that a lncRNA, named cardiac apoptosis-related lncRNA (CARL), can suppress mitochondrial fission and apoptosis by targeting miR-539 and PHB2. The results show that PHB2 is able to inhibit mitochondrial fission and apoptosis. miR-539 is responsible for the dysfunction of PHB2 and regulates mitochondrial fission and apoptosis by targeting PHB2. Further, we show that CARL can act as an endogenous miR-539 sponge that regulates PHB2 expression, mitochondrial fission and apoptosis. Our present study reveals a model of mitochondrial fission regulation that is composed of CARL, miR-539 and PHB2. Modulation of their levels may provide a new approach for tackling apoptosis and myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710105     DOI: 10.1038/ncomms4596

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  174 in total

Review 1.  Characters, functions and clinical perspectives of long non-coding RNAs.

Authors:  Ruifang Wu; Yuwen Su; Haijing Wu; Yong Dai; Ming Zhao; Qianjin Lu
Journal:  Mol Genet Genomics       Date:  2016-02-17       Impact factor: 3.291

Review 2.  Long noncoding RNAs in cardiac development and ageing.

Authors:  Yvan Devaux; Jennifer Zangrando; Blanche Schroen; Esther E Creemers; Thierry Pedrazzini; Ching-Pin Chang; Gerald W Dorn; Thomas Thum; Stephane Heymans
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

3.  Long non-coding RNAs in heart failure: an obvious lnc.

Authors:  Hamid El Azzouzi; Pieter Adrianus Doevendans; Joost Petrus Gerardus Sluijter
Journal:  Ann Transl Med       Date:  2016-05

4.  Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137.

Authors:  Zong Wang; Jiangwei Yuan; Li Li; Yang Yang; Xuchang Xu; Ying Wang
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation.

Authors:  Ainara Castellanos-Rubio; Radomir Kratchmarov; Maialen Sebastian; Koldo Garcia-Etxebarria; Liher Garcia; Iñaki Irastorza; Sankar Ghosh
Journal:  J Immunol       Date:  2017-06-16       Impact factor: 5.422

Review 6.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 7.  Long noncoding RNAs in lipid metabolism.

Authors:  Coen van Solingen; Kaitlyn R Scacalossi; Kathryn J Moore
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

8.  Clopidogrel reduces apoptosis and promotes proliferation of human vascular endothelial cells induced by palmitic acid via suppression of the long non-coding RNA HIF1A-AS1 in vitro.

Authors:  Jing Wang; Lingqiang Chen; Hongfei Li; Jin Yang; Zhiqiang Gong; Bing Wang; Xueling Zhao
Journal:  Mol Cell Biochem       Date:  2015-03-12       Impact factor: 3.396

Review 9.  Long non-coding RNAs regulating macrophage functions in homeostasis and disease.

Authors:  Kaitlyn R Scacalossi; Coen van Solingen; Kathryn J Moore
Journal:  Vascul Pharmacol       Date:  2018-03-13       Impact factor: 5.773

10.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.

Authors:  H Cai; X Liu; J Zheng; Y Xue; J Ma; Z Li; Z Xi; Z Li; M Bao; Y Liu
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.